financetom
Business
financetom
/
Business
/
WEX Obtains Preliminary Injunction Against HP
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WEX Obtains Preliminary Injunction Against HP
Jul 10, 2024 11:10 AM

01:39 PM EDT, 07/10/2024 (MT Newswires) -- WEX (WEX) said Wednesday it obtained a preliminary injunction to stop HP (HPQ) and Hewlett-Packard Development from using the "WEX" name.

The company said Judge John Woodcock Jr. of the US District Court for the District of Maine granted the injunction Tuesday, saying WEX "would suffer irreparable harm" without an injunction because HP is launching its WEX platform before the case goes to trial.

"The Court determines the plaintiff is likely to succeed on the merits because the marks at issue are nearly identical, the products are similar, the parties use the same marketing terms to promote the products, the plaintiff's marks are strong, and the plaintiff has put forth convincing evidence of actual confusion," the court stated.

WEX Chief Legal Officer Sara Trickett said the company is looking to obtain a permanent injunction at trial.

HP did not immediately respond to MT Newswires' request for comment.

Shares of WEX were down 1.6% in recent trading, while HP shares were up 1.7%.

Price: 175.12, Change: -2.92, Percent Change: -1.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Nov 13, 2025
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™ platform Combined company has pro forma cash of $14 million following merger and closing of recent public offering HOUSTON and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals ( SLRX ) (“Salarius” or the “Company”) and Decoy Therapeutics...
First Mining Gold's Q3 Loss Widens as Project Work Continues
First Mining Gold's Q3 Loss Widens as Project Work Continues
Nov 13, 2025
08:17 AM EST, 11/13/2025 (MT Newswires) -- First Mining Gold ( FFMGF ) said Thursday that its net loss widened in the third quarter. The company reported a net loss and comprehensive loss of C$21.5 million, or a loss of $0.02 per share, in the three months ended Sept. 30, compared to a year-ago loss of $5.7 million, or a...
Tidewater Renewables Narrows Q3 Loss Despite Lower Revenue
Tidewater Renewables Narrows Q3 Loss Despite Lower Revenue
Nov 13, 2025
08:15 AM EST, 11/13/2025 (MT Newswires) -- Tidewater Renewables ( TDWRF ) on Thursday reported a narrowed net loss in the third quarter despite a fall in revenue. For the three months ended Sept. 30, net loss was $1.0 million or $0.03 loss per diluted share compared with a net loss of $367.1 million or $10.46 loss per diluted share,...
BioNTech says collaboration with Pfizer remains unchanged
BioNTech says collaboration with Pfizer remains unchanged
Nov 13, 2025
FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer ( PFE ) has not changed, when asked to comment on a report that Pfizer ( PFE ) is looking to sell its stake in the German biotech firm. We continue to have a close and strong collaboration, a spokesperson said in a statement, adding that BioNTech would not...
Copyright 2023-2026 - www.financetom.com All Rights Reserved